Literature DB >> 2115190

The outcome of community acquired pneumonia treated on the intensive care unit.

M Alkhayer1, P F Jenkins, B D Harrison.   

Abstract

Eighteen patients with community acquired pneumonia required intensive care for severe or progressive hypoxaemia, rising arterial carbon dioxide tension or respiratory arrest, and 17 received intermittent positive pressure ventilation. Thirteen survived to leave hospital and 12 are long term survivors. Ventilation was started within 4 days of admission in all cases and was continued for up to 34 days; six patients required ventilation for over 3 weeks. The most common medical complication was renal failure. The most common iatrogenic complication was pneumothorax. We believe that all the hypoxic patients would have died from their hypoxia had it not been corrected. We estimated that up to 5% of patients admitted with community acquired pneumonia need intensive care. This study demonstrates the effectiveness of such care, which is multidisciplinary, demanding, and may need to be prolonged.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115190     DOI: 10.1016/s0954-6111(08)80087-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  Grand Rounds--City Hospital, Nottingham. A complicated case of community acquired pneumonia.

Authors:  S R Johnson; I D Pavord
Journal:  BMJ       Date:  1996-04-06

4.  A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.

Authors:  P M Olaechea; J M Quintana; M S Gallardo; J Insausti; E Maraví; B Alvarez
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

5.  Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.

Authors:  Mark Woodhead; Catherine A Welch; David A Harrison; Geoff Bellingan; Jon G Ayres
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 6.  Practical considerations and guidelines for the management of community-acquired pneumonia.

Authors:  R G Finch; M A Woodhead
Journal:  Drugs       Date:  1998-01       Impact factor: 11.431

7.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.

Authors:  Andrew P Walden; Geraldine M Clarke; Stuart McKechnie; Paula Hutton; Anthony C Gordon; Jordi Rello; Jean-Daniel Chiche; Frank Stueber; Christopher S Garrard; Charles J Hinds
Journal:  Crit Care       Date:  2014-04-01       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.